ANNOUNCEMENT: Sativa Wellness Group announces Appointment of Arden Partners
Sativa Wellness Group is pleased to announce today that it has appointed Arden Partners Plc (“Arden”) as the Company’s AQSE Corporate Adviser and Broker.
Sativa Wellness Group is pleased to announce today that it has appointed Arden Partners Plc (“Arden”) as the Company’s AQSE Corporate Adviser and Broker.
Sativa Wellness Group Inc. is pleased to announce today that it has partnered with Superdrug Stores Plc (“Superdrug”) to offer an extensive range of blood tests.
Sativa Wellness Group Inc. is pleased to announce today a second quarterly profit in Q3 2021. The Company has filed the Financial Statements and Management’s Discussion and Analysis for Q3 September 2021, demonstrating continued strong growth.
Sativa Wellness Group Inc. is pleased to announce today that Monday this week saw the highest number of tests booked in a day exceeding 850 tests and £100,000 (C$180,000) of revenue. While the majority of tests are still COVID-19 tests for travellers, the proportion of blood tests being booked is growing consistently.
The Court Meeting to consider and, if thought fit, approve the Scheme and the General Meeting to consider and, if thought fit, pass the Special Resolution relating to the Acquisition were each held yesterday.
Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.
Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.
Further to the announcement made by the Company on 3 June 2020 (the “Rule 2.7 Announcement”), Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has yesterday, 22 June, issued a Part 8 Claim Form dated 22 June 2020 in the Companies Court for an Order under Section 896 of the Companies Act 2006 to convene on 14 August 2020 at 11 a.m…
• Further to the announcements made on 22 April 2020 and 20 May 2020, the boards of directors of Stillcanna Inc. (“Stillcanna”) and Sativa Group plc (“Sativa” or the “Company”) are pleased to announce that they have reached agreement on the terms of a recommended share for share exchange offer to be made by Stillcanna for the entire issued and to be issued share capital of Sativa (the “Offer”).
In accordance with Rule 2.6(c) of the Code, at the request of the Directors of Sativa, the Panel on Takeovers & Mergers (the “Panel”) has consented to an extension of the relevant deadline, until 5:00 p.m. on 3 June 2020 to enable the parties to complete the compilation…